Ventana Medical Systems Inc - Product Pipeline Analysis, 2017 Update

Summary

Ventana Medical Systems Inc (VMS), a subsidiary of F. Hoffmann-La Roche Ltd is a manufacturer of tissue-based diagnostic solutions for healthcare market. The company develops cancer diagnostic solutions for breast pathology, cervical diagnostics, colorectal pathology, special stains, lung pathology, dermatopathology, hematopathology and prostate pathology. The company offers detection systems such as ultraVIEW SISH Detection Kit, ISH iVIEW Blue Plus detection kit, ultraView Red ISH DIG detection kit and ultraView SISH DNP detection kit.VMS also offers technical and application support services. The company markets its products through its channel of network distributors. VMS is headquartered in Tucson, Arizona, the US.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Ventana Medical Systems Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Ventana Medical Systems Inc Company Overview 5
Ventana Medical Systems Inc Company Snapshot 5
Ventana Medical Systems Inc Pipeline Products and Ongoing Clinical Trials Overview 5
Ventana Medical Systems Inc Pipeline Analysis Overview 8
Ventana Medical Systems Inc - Key Facts 8
Ventana Medical Systems Inc - Major Products and Services 9
Ventana Medical Systems Inc Pipeline Products by Development Stage 12
Ventana Medical Systems Inc Pipeline Products Overview 14
BLU-554 Companion Diagnostic Assay - Hepatocellular Carcinoma 14
BLU-554 Companion Diagnostic Assay - Hepatocellular Carcinoma Product Overview 14
CD30 Companion Diagnostic Test 15
CD30 Companion Diagnostic Test Product Overview 15
Companion Diagnostic Assay - Cancer 16
Companion Diagnostic Assay - Cancer Product Overview 16
Companion Diagnostic HuMax -TF-ADC 17
Companion Diagnostic HuMax -TF-ADC Product Overview 17
Companion Diagnostic Test - Cancer 18
Companion Diagnostic Test - Cancer Product Overview 18
Companion Diagnostic Test - Multiple Cancer 19
Companion Diagnostic Test - Multiple Cancer Product Overview 19
ImmunoGens Companion Diagnostic Test 20
ImmunoGens Companion Diagnostic Test Product Overview 20
PD-L1 Companion Diagnostics Assay 21
PD-L1 Companion Diagnostics Assay Product Overview 21
PEGPH20 Companion Diagnostic Assay - Pancreatic Cancer 22
PEGPH20 Companion Diagnostic Assay - Pancreatic Cancer Product Overview 22
VENTANA System For Primary Diagnosis 23
VENTANA System For Primary Diagnosis Product Overview 23
Ventana Medical Systems Inc - Key Competitors 24
Ventana Medical Systems Inc - Key Employees 25
Ventana Medical Systems Inc - Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 27
Ventana Medical Systems Inc, Recent Developments 27
Nov 07, 2016: FDA approves Roches VENTANA ALK (D5F3) CDx Assay for use on the VENTANA BenchMark ULTRA system 27
Feb 22, 2016: FDA-approved ALK IHC CDx superior to another IHC assay for patient selection 27
Jun 15, 2015: Ventana receives FDA approval for the first fully automated IHC companion diagnostic to identify lung cancer patients eligible for XALKORI 28
Mar 03, 2015: Global scientific collaborators to explore latest pathology and oncology advancement at Tucson Symposium 28
Jan 21, 2015: Ventana seeks FDA premarket approval for ALK IHC companion diagnostic to benefit lung cancer patients 29
Oct 28, 2014: Ventana announces collaboration to develop companion diagnostics for ImmunoGens targeted anticancer agents 29
Aug 20, 2014: New CE mark in the European Union extends application to routine pathology including primary diagnosis with human tissue specimens 30
Aug 05, 2014: Ventana paves the way for companion diagnostic early phase clinical trials in China to advance patient care 30
Jun 04, 2014: Ventana Medical Systems and MedImmune collaborate to develop a custom PD-L1 Assay for immunotherapy clinical trials 31
May 21, 2014: Ventana Companion Diagnostics CAP/CLIA lab launches new Robust Prototype Assays 31
Appendix 33
Methodology 33
About GlobalData 35
Contact Us 35
Disclaimer 35

List Of Tables


Ventana Medical Systems Inc Pipeline Products and Ongoing Clinical Trials Overview 5
Ventana Medical Systems Inc Pipeline Products by Equipment Type 6
Ventana Medical Systems Inc Pipeline Products by Indication 7
Ventana Medical Systems Inc, Key Facts 8
Ventana Medical Systems Inc, Major Products and Services 9
Ventana Medical Systems Inc Number of Pipeline Products by Development Stage 12
Ventana Medical Systems Inc Pipeline Products Summary by Development Stage 13
BLU-554 Companion Diagnostic Assay - Hepatocellular Carcinoma - Product Status 14
BLU-554 Companion Diagnostic Assay - Hepatocellular Carcinoma - Product Description 14
CD30 Companion Diagnostic Test - Product Status 15
CD30 Companion Diagnostic Test - Product Description 15
Companion Diagnostic Assay - Cancer - Product Status 16
Companion Diagnostic Assay - Cancer - Product Description 16
Companion Diagnostic HuMax -TF-ADC - Product Status 17
Companion Diagnostic HuMax -TF-ADC - Product Description 17
Companion Diagnostic Test - Cancer - Product Status 18
Companion Diagnostic Test - Cancer - Product Description 18
Companion Diagnostic Test - Multiple Cancer - Product Status 19
Companion Diagnostic Test - Multiple Cancer - Product Description 19
ImmunoGens Companion Diagnostic Test - Product Status 20
ImmunoGens Companion Diagnostic Test - Product Description 20
PD-L1 Companion Diagnostics Assay - Product Status 21
PD-L1 Companion Diagnostics Assay - Product Description 21
PEGPH20 Companion Diagnostic Assay - Pancreatic Cancer - Product Status 22
PEGPH20 Companion Diagnostic Assay - Pancreatic Cancer - Product Description 22
VENTANA System For Primary Diagnosis - Product Status 23
VENTANA System For Primary Diagnosis - Product Description 23
Ventana Medical Systems Inc, Key Employees 25
Ventana Medical Systems Inc, Subsidiaries 26
Glossary 34

List Of Figures

List of Figures
Ventana Medical Systems Inc Pipeline Products by Equipment Type 6
Ventana Medical Systems Inc Pipeline Products by Development Stage 12

Ventana Medical Systems Inc - Medical Equipment - Deals and Alliances Profile.

Ventana Medical Systems Inc (VMS), a subsidiary of F. Hoffmann-La Roche Ltd is a manufacturer of tissue-based diagnostic solutions for healthcare market. The company develops cancer diagnostic solutions for breast

USD 250 View Report

Canon Medical Systems Full Year Operating

Canon Medical Systems 2023 Full Year Operating and Financial Review--SWOT Analysis, Technological Know-How, M&A, Senior Management, Goals and Strategies in the Global Diagnostic Imaging Industry This report is part of

USD 750 View Report

Canon Medical Systems 2023 Third Quarter Operating and Financial Review

Canon Medical Systems 2023 Third Quarter Operating and Financial Review--SWOT Analysis, Technological Know-How, M&A, Senior Management, Goals and Strategies in the Global Diagnostic Imaging Industry This report is part of

USD 750 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available